Aegerion Pharmaceuticals

Aegerion Pharmaceuticals is a biopharmaceutical company that develops and markets medications for rare genetic disorders. Its primary focus is on rare conditions that affect how the body processes lipids (fats), such as severe cases of high cholesterol. They create specialized drugs to help manage these diseases, improving patients’ health outcomes. Aegerion’s goal is to address unmet medical needs in underserved patient populations through innovative treatments based on understanding complex genetic and metabolic processes.